Liquid cytology in comparison with traditional in the diagnosis of cervical diseases
https://doi.org/10.25789/YMJ.2020.70.05
Abstract
This paper presents the results of a cytological study of patients with pathology of the cervix uteri (CU) based on traditional cytology (TC) and on liquid-based cytology (LBC). It was found that the combined use of liquid-based cytology and conventional cytology can improve the effectiveness of CU pathology diagnostics. It is recommended to complete the cytological study with testing for human papillomavirus (HPV). The use of these screening methods (cytological and HPV tests) contribute to improving the early diagnosis, monitoring, and prognosis of CU cancer.
About the Authors
M. P. KirillinaRussian Federation
Kirillina Maria Petrovna – Candidate of Biological Sciences, Senior Research Scientist, Head;
Head
89142716881
S. I. Sofronova
Russian Federation
Sofronova Sargylana Ivanovna – Candidate of Medicine, Senior Research Associate, Head of Scientific and Organizational Department
89841094825
I. V. Kononova
Russian Federation
Kononova Irina Vasilievna – Candidate of Medical Science, Research Worker
89243683673
A. K. Ivanova
Russian Federation
Ivanova Anna Konstantinovna – Сlinical pathologist (cytology);
Clinical Pathologist
89248647588
V. A. Vorontsova
Russian Federation
E. L. Lushnikova
Russian Federation
Lushnikova Elena Leonidovna – Doctor of Biological Science, professor, the head
630117,Novosibirsk,Timakova st.,2
8(383)334-80-03
References
1. Bovykina G.A. Cytological study - early diagnosis of cervical cancer / G.A. Bovykina // Laboratory diagnosis. - №4 (134). - 2015. – p. 35-37. https://cyberleninka.ru/article/n/tsitologicheskoe-issledovanierannyaya-diagnostika-raka-sheyki-matki/viewer
2. Malignant neoplasms in Russia in 2007 (morbidity and mortality) / Ed. I.V. Chissov, V.V. Starinsky, G.V. Petrova. M.: FGU «P.A. Herzen Russian Technologies MNII”, 2009. - 244 p.
3. Clinical and morphological aspects of cervical papillomavirus infection / L.A. Kolomiets, L.N. Urazova, N.V. Sevastyanova [et al.] // Oncology Issues. - 2002. -V. 48, №1. - P.43–46.
4. Kasoyan K.T. The method of liquid cytology in the diagnosis of cervical diseases: a training manual / K.T.Kasoyan, T.V.Dzhangirova // M.: RMAPO. – 2012. – 23p. http://irbis.rmapo.ru/UploadsFilesForIrbis/f303d0ae387de4afa8b027efec7db8ed.pdf
5. Kazaishvili T.N. Early diagnosis of cervical cancer by liquid cytology. Research and practice in medicine. National Congress “Oncology of reproductive organs from prevention and early detection to effective treatment” / T.N.Kazaishvili. - M.: KVAZAR, 2016. – p.80-81. https://cyberleninka.ru/article/v/rannyaya-diagnostika-raka-sheyki-matki-metodom-zhidkostnoy-tsitologii-1
6. Kogan E.A. Monitoring of patients who underwent cervical conization for cervical intraepithelial neoplasia (clinical, morphological and molecular biological aspects of the problem) / E.A. Kogan, N.M. Fayzullina, A.Kh. Israilova // Obstetrics and gynecology. - 2012. - №1. – p.70-74. https://aig-journal.ru/articles/Monitoring-bolnyh-perenesshih-operaciu-konizacii-sheiki-matki-po-povodu-cervikalnoi-intraepitelialnoi-neoplazii-kliniko-morfologicheskie-i-molekulyarn.html
7. Prilepskaya V.N. Diseases of the cervix, vagina and vulva / B.N. Prilepskaya. -M. -MED pre-inform, 2005. - P.432.
8. The role of virological factors in the development of cervical cancer in young women / L.A. Evstigneeva, E.V. Bakhidze, V.V. Semiglazov [et al.] // Journal of Obstetrics and Women's Diseases. - 2007. - V. LVII. - p.153-154. http://www.oncology.tomsk.ru/nii/journal/2012/3/files/soj_2012_3_34-40.pdf
9. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis / M.E.Sherman, A.T.Lorincz, D.R.Scott [et al.] // J. Natl. Cancer Inst. - 2003. - Vol. 95. -P.46–52.
10. Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting / H.Hoyer, C.Scheungraber, R. KuehneHeid [et al.] // Int.J. Cancer. - 2005. - Vol. 116. - P. 136–143.
11. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses / M.Arbyn, P.Sasieni, C.Meijer [et al.] // Vaccine. - 2006. - Vol. 24. - Suppl. 3. - p.78–89.
12. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial /G.Ronco, P.Giorgi-Rossi, F. Carozzi [et al.] // Lancet Oncol. – 2010. – Vol. 11, № 3. – P. 249–257. https://www.ncbi.nlm.nih.gov/ pubmed/20089449
13. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients / K.U.Petry, S. Menton, M.Menton [et al.] // Br. J. Cancer. - 2003. - Vol. 88. - P. 1570–1577.
14. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage :randomised study within organised screening programme/ A.Anttila, L.Kotaniemi-Talonen, M. Leinonen [et al.] // BMJ. – 2010. – Vol. 340. – P. 1804. https://www.bmj.com/content/340/bmj.c1804
15. Type – specific human papillomavirus DNA in abnormal smears as a predictor of high – grade cervical intraepithelial neoplasia / J.Cuzick, G.Terry, L.Ho [et al.] // Br. J. Cancer. 1994. - Vol. 69. - P.167–171.
16. The Bethesda System for Reporting Cervical Cytology: Definitions, criteria, and explanatory notes. / Springer. 3rd Edition. Nayar, Ritu; Wilbur, David C. (Eds), 2015.– p.321. https://link.springer.com/content/pdf/10.1007%2F978-3-319-11074-5.pdf
Review
For citations:
Kirillina M.P., Sofronova S.I., Kononova I.V., Ivanova A.K., Vorontsova V.A., Lushnikova E.L. Liquid cytology in comparison with traditional in the diagnosis of cervical diseases. Yakut Medical Journal. 2020;(2):18-20. https://doi.org/10.25789/YMJ.2020.70.05